$BMRN
Análise IAGerado em May 11, 2026
AI Score
Hold$BMRN
BioMarin Pharmaceutical
$BMRNNASDAQHealthcareLarge-Cap
BioMarin develops treatments for rare diseases including Voxzogo for achondroplasia and enzyme replacement therapies.
Market Cap
$14.0B
Revenue (TTM)
$2.7B
+12.0%
Net Income (TTM)
$0.4B
+25.0%
EPS (TTM)
$2.00
P/E Ratio
32.0
Dividend Yield
0.0%
52-Week Range
$65-$100
Beta
0.52
Dimension Scores
Fundamental
64Technical
64Sentiment
72Risk / Reward
64Momentum
72Financial Health
Profitability
69moderate
Growth
75strong
Liquidity
72strong
Solvency
66strong
Efficiency
62moderate
Valuation, technical analysis, investment thesis, risk assessment and more for $BMRN
Free · No credit card required
Aviso: Análise gerada por IA apenas para fins educacionais. Não constitui aconselhamento financeiro. Sempre consulte um consultor financeiro qualificado.